TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that in the second quarter of 2024, it has launched a Baclofen 15mg Tablet product on a TruPharma label. The FDA-approved product is being supplied to TruPharma pursuant to an agreement with Rubicon Research Private Limited. Significantly, Rubicon holds one of the only two FDA approvals for a 15 mg strength Baclofen Tablet product, and TruPharma will be the first to market this limited source item.